Follow the ソレイジア・ファーマ株式会社 share price and the full insider trade history of the company, a publicly traded company based in Japan. Shares are listed on the JP market, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, ソレイジア・ファーマ株式会社 has recorded 36 reports. Market capitalisation: €7.6bn. The latest transaction was disclosed on 16 January 2026 (Holding update). Among the most active insiders: Macquarie Bank Limited. Every trade is free.
36
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,845 of 28,549 companies
24.9
score / 100
Value
14
Quality
36
FCF yld-14%
Earn yld-11%
EV/EBITDA·
ROE-70%
Gross mgn48%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Solexia Pharma Co., Ltd. es una empresa enfocada en el sector de la salud y farmacéutico, dedicada al desarrollo de tratamientos innovadores. Cotiza en el mercado XTKS.